---
title: "CHENGDA PHARMA (301201.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301201.SZ/norm.md"
symbol: "301201.SZ"
name: "CHENGDA PHARMA"
parent: "https://longbridge.com/en/quote/301201.SZ.md"
datetime: "2026-03-09T20:12:24.413Z"
locales:
  - [en](https://longbridge.com/en/quote/301201.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301201.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301201.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301201.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301201.SZ/norm.md)


# CHENGDA PHARMA (301201.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0260 | 0.0944 | -0.0092 | -0.4525 | 0.1005 |
| ROE | 0.74% | 2.65% | -0.26% | -12.53% | 2.72% |
| Revenue | 102.64M | 106.15M | 76.31M | 89.36M | 79.76M |
| Net income | 3.95M | 14.22M | -1.40M | -68.50M | 15.22M |
| Operating income | 9.56M | 7.13M | -6.27M | -83.23M | 17.11M |
| Gross margin | 48.75% | 40.21% | 48.07% | 21.99% | 58.27% |
| Net margin | 3.85% | 13.40% | -1.83% | -76.65% | 19.08% |
| Profit quality | 22.20% | 15.38% | - | - | 152.65% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.37B | 2.41B | 2.39B | 2.44B | 2.40B |
| Leverage | 1.11 | 1.12 | 1.11 | 1.14 | 1.07 |
| BVPS | 14.06 | 14.23 | 14.14 | 14.15 | 14.73 |
| Turnover | 0.1572 | 0.1460 | 0.1287 | 0.1362 | 0.1662 |
| Cash & STI | 982.90M | 1.10B | 1.09B | 1.14B | 1.18B |
| Inv & Rec | 154.09M | 153.01M | 127.03M | 135.27M | 128.37M |
| LT assets | 846.21M | 824.23M | 827.53M | 872.25M | 706.94M |
| Net debt | -924.71M | -1.01B | -1.00B | -1.06B | -1.18B |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 43.07M | 46.35M | -22.96M | -29.27M | 11.21M |
| Investing CF | 2.30M | 303.43M | 307.30M | -350.35M | -444.12M |
| Financing CF | -59.68M | -631103.00 | 7.47M | 78.67M | -30.50M |
| Free CF | -51.05M | 13.92M | -131.82M | -42.05M | -79.50M |
| OCF coverage | 44.96% | 115.33% | -64.71% | -28.54% | 13.30% |
| Repaid & issued | 0.0000 | 0.0000 | 8.08M | 80.12M | - |
| CapEx | -36.12M | -39.56M | -34.88M | -101.14M | -55.16M |

## Distribution Plan

**Dividend Yield**: 0.46

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.195805CNY | 2025-07-09 | 2025-07-10 | 2025-07-10 |
| Cash Dividend: 
0.195944CNY | 2024-07-09 | 2024-07-10 | 2024-07-10 |
| Cash Dividend: 
0.3CNY. 
Share conversation: 0.6 for 1 | 2023-07-06 | 2023-07-07 | 2023-07-07 |